consuelo climent

Dr. consuelo climent


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
TSTara Steffen
Tara Steffen
TSTaylor Stone
Taylor Stone
MHMariah Hassert
Mariah Hassert
EGElizabeth Geerling
Elizabeth Geerling
BGBrian Grimberg
Brian Grimberg
JBJames Brien
James Brien
Natural infection of SARS-CoV-2 in humans leads to the development of a strong neutralizing antibody response, however the immunodominant targets of the polyclonal neutralizing antibody response are still unknown. Here, we functionally define the role SARS-CoV-2 spike plays as a target of the human neutralizing antibody response. In this study, we identify the spike protein subunits that contain antigenic determinants and examine the neutralization capacity of polyclonal sera from a cohort of patients that tested qRT-PCR-positive for SARS-CoV-2. Using an ELISA format, we assessed binding of human sera to spike subunit 1 (S1), spike subunit 2 (S2) and the receptor binding domain (RBD) of spike. To functionally identify the key target of neutralizing antibody, we depleted sera of subunit-specific antibodies to determine the contribution of these individual subunits to the antigen-specific neutralizing antibody response. We show that epitopes within RBD are the target of a majority of the neutralizing antibodies in the human polyclonal antibody response . These data provide critical information for vaccine development and development of sensitive and specific serological testing.

RRRosa Rosario-Rosado
Rosa Rosario-Rosado
CNCruz Nazario
Cruz Nazario
JHJohan Hernández-Santiago
Johan Hernández-Santiago
MSMichelle Schelske-Santos
Michelle Schelske-Santos
IMImar Mansilla-Rivera
Imar Mansilla-Rivera
JFJo Freudenheim
Jo Freudenheim
Global breast cancer incidence varies considerably, particularly in comparisons of low- and high-income countries; rates may vary even within regions. Breast cancer rates for Caribbean countries are generally lower than for North America and Europe. Rates in Puerto Rico are in the middle of the range between the highest and the lowest Caribbean countries. Populations in transition, with greater variability in risk factor exposures, provide an important opportunity to better understand breast cancer etiology and as potential sources of variation in rates. Understanding of exposures across the life span can potentially contribute to understanding regional differences in rates. We describe here the design and implementation of a population-based, case-control study in the San Juan Metropolitan Area (SJMA) of Puerto Rico, the Atabey Epidemiology of Breast Cancer Study. We describe steps taken to ensure that the study was culturally appropriate, leveraging the Atabey researchers’ understanding of the culture, local health system, and other required resources to effectively recruit participants. A standardized, in-person interview was developed, with attention to life course events customized to the study population. In order to understand variation in global breast cancer rates, studies customized to the populations outside of North America and Europe are required.

1 March 2020 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
RBRaisa I. Balbuena-Merle
Raisa I. Balbuena-Merle
CNCruz Nazario
Cruz Nazario
RRRosa Rosario-Rosado
Rosa Rosario-Rosado
DMDalia Millán-Tapia
Dalia Millán-Tapia
CCconsuelo climent
consuelo climent
Balbuena-Merle RI, et al. Ann Lab Med. 2020 Mar;40(2):187-189. https://doi.org/10.3343/alm.2020.40.2.187